235 related articles for article (PubMed ID: 17272517)
1. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
[TBL] [Abstract][Full Text] [Related]
3. The role of CCL3/macrophage inflammatory protein-1alpha in experimental colitis.
Ajuebor MN; Kunkel SL; Hogaboam CM
Eur J Pharmacol; 2004 Aug; 497(3):343-9. PubMed ID: 15336953
[TBL] [Abstract][Full Text] [Related]
4. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
5. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
[TBL] [Abstract][Full Text] [Related]
6. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
7. Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis.
Teramoto K; Miura S; Tsuzuki Y; Hokari R; Watanabe C; Inamura T; Ogawa T; Hosoe N; Nagata H; Ishii H; Hibi T
Clin Exp Immunol; 2005 Mar; 139(3):421-8. PubMed ID: 15730387
[TBL] [Abstract][Full Text] [Related]
8. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
9. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
10. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease.
Kwon JH; Keates S; Bassani L; Mayer LF; Keates AC
Gut; 2002 Dec; 51(6):818-26. PubMed ID: 12427784
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
13. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
14. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
15. Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice.
Lúdvíksson BR; Strober W; Nishikomori R; Hasan SK; Ehrhardt RO
J Immunol; 1999 Apr; 162(8):4975-82. PubMed ID: 10202045
[TBL] [Abstract][Full Text] [Related]
16. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver.
Shimizu Y; Murata H; Kashii Y; Hirano K; Kunitani H; Higuchi K; Watanabe A
Hepatology; 2001 Aug; 34(2):311-9. PubMed ID: 11481616
[TBL] [Abstract][Full Text] [Related]
17. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody.
Wittig B; Schwärzler C; Föhr N; Günthert U; Zöller M
J Immunol; 1998 Aug; 161(3):1069-73. PubMed ID: 9686562
[TBL] [Abstract][Full Text] [Related]
18. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
Srinivasan M; Summerlin DJ
Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-inflammatory protein-3alpha mediates epidermal growth factor receptor transactivation and ERK1/2 MAPK signaling in Caco-2 colonic epithelial cells via metalloproteinase-dependent release of amphiregulin.
Keates S; Han X; Kelly CP; Keates AC
J Immunol; 2007 Jun; 178(12):8013-21. PubMed ID: 17548638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
